Toggle menu
Products and Services
Discovery
and
Research
QIAGEN IPA
QIAGEN CLC Genomics
QIAGEN OmicSoft
Clinical
and
Translational
QCI
HGMD
QCI Interpret Translational
Services
Discovery
Clinical
Real-World Insights
Solutions
Discovery
and
Research
Biomarker and Target Discovery
Single-cell Genomics
Gene Regulation
Microbial/Metagenomics
Data and pipeline management
Clinical
and
Translational
Hereditary Diseases
Oncology
Clinical Analysis and Interpretation Services
Case stories
Overview
CLC User Group Meeting
IPA + OmicSoft User Group Meeting
Webinars
Discovery
and
Research
QIAGEN IPA
QIAGEN CLC Genomics
QIAGEN OmicSoft
Clinical
and
Translational
QCI Interpret
QCI Precision Insights
QCI Interpret One
QCI Interpret Translational
HGMD
Complete
c
ollection
Upcoming
w
ebinars
Tutorials
QIAGEN IPA
Biomedical Genomics Analysis
QIAGEN CLC Genomics Workbench
QIAGEN OmicSoft
CLC Genome Finishing Module
CLC Microbial Genomics Module
QCI Interpret Translational
HGMD
QCI Interpret
Enterprise Solution
日本語 (Japanese)
Home
COSMIC
COSMIC Actionability Introduction
COSMIC
COSMIC Actionability Introduction
41 views
February 03, 2021
Senior scientific curator, Steve Jupe provides an introduction to COSMIC's new Actionability product, Mutation Actionability in Precision Oncology ahead of it's release in early 2021.
COSMIC Actionability Introduction
0
Share
Embed
URL to share
Embed this video
Download this video
Standard
(14MB)
HD
(18MB)